Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The human virome: assembly, composition and host interactions


The human body hosts vast microbial communities, termed the microbiome. Less well known is the fact that the human body also hosts vast numbers of different viruses, collectively termed the ‘virome’. Viruses are believed to be the most abundant and diverse biological entities on our planet, with an estimated 1031 particles on Earth. The human virome is similarly vast and complex, consisting of approximately 1013 particles per human individual, with great heterogeneity. In recent years, studies of the human virome using metagenomic sequencing and other methods have clarified aspects of human virome diversity at different body sites, the relationships to disease states and mechanisms of establishment of the human virome during early life. Despite increasing focus, it remains the case that the majority of sequence data in a typical virome study remain unidentified, highlighting the extent of unexplored viral ‘dark matter’. Nevertheless, it is now clear that viral community states can be associated with adverse outcomes for the human host, whereas other states are characteristic of health. In this Review, we provide an overview of research on the human virome and highlight outstanding recent studies that explore the assembly, composition and dynamics of the human virome as well as host–virome interactions in health and disease.


We are becoming accustomed to the idea that healthy humans are colonized by a rich diversity of microorganisms — the microbiome. However, less well known is that healthy humans are also colonized by a remarkable diversity of viruses — the virome. The human virome comprises bacteriophages (phages) that infect bacteria, viruses that infect other cellular microorganisms such as archaea, viruses that infect human cells and viruses present as transients in food1,2,3,4,5,6,7.

Centuries of medical research have linked infection by specific viruses with characteristic disease states; however, the nature and importance of whole viral populations were mostly not appreciated until the development of advanced DNA sequencing methods that could report the structures of whole communities. Untargeted sequencing of purified viral samples, termed ‘shotgun sequencing’, was first applied to environmental viral populations in 2002 by Breitbart et al. Viral particles were prepared from seawater, and then shotgun metagenomic sequencing was employed to characterize the viral communities present8, revealing highly abundant and diverse phage genomes, as well as a large proportion of viral ‘dark matter’ (that is, sequences that looked like nothing in available databases). The next year, the same research group carried out the first study of whole viral communities from human faeces1, again revealing rich and diverse viral populations, and emphasizing how little of this diversity had been studied previously. Since then, similar methods have been applied in many studies of virome populations, providing a rich picture of the associations of the human virome with health and disease, and continuing to emphasize the expanse of viral dark matter (reviewed in refs9,10).

The discovery of so much dark matter is not surprising, given that seawater has ~107 virus-like particles (VLPs) per millilitre and faeces ~109 VLPs per gram. In these studies, particles that look like viral particles are not commonly verified as replication competent; thus, the term VLP is used to reflect the fact that we are uncertain that these particles are replication-competent viruses, although for many it seems likely. These vast populations, inferred to be mostly unstudied phages, are extremely diverse in the number of types as well as overall numbers of particles. Furthermore, in a few cases, viral lineages have been shown to evolve rapidly, also contributing to the observed rich sequence variation4. The National Center for Biotechnology Information (NCBI) Genomes database contains only 10,462 complete viral genome sequences (as of February 2021), a tiny fraction of the global diversity. Thus, studying the virome is exciting for the extent of the novelty in every experiment, but also daunting for the analytical challenges.

Viral populations vary greatly across the human body. The human gut contains the most abundant populations, and these have been the most studied. This site is rich in cells of both the human gut and prokaryotic microbiota, providing a rich variety of hosts for viral growth. Most other sites have sparser microbiota, at least in healthy individuals, and so sparser viral populations as well; however, recent work has defined rich viral populations at many locations throughout the human body. A high degree of inter-individual variation is seen in the human virome, paralleling findings from bacterial and fungal communities, raising questions of to what extent inter-individual differences in phenotypes are attributable to differences in the virome (Table 1).

Table 1 Examples of viral population alterations in human disorders

Recent studies have uncovered numerous factors that show associations with virome structure in addition to anatomical location, such as diet, age and geographic location of the individual sampled. Disease is another prominent influence, with emerging studies suggesting associations between virome structure and inflammatory bowel disease, diabetes, hypertension and cancer11,12,13,14,15,16,17,18,19. Most studies have only reported associations of the virome and diseases — thus, more work is needed to understand the directions of causal relationships.

In this Review, we provide an overview of research on the human virome, focusing both on secure conclusions and on areas where additional work would be helpful. We first discuss the virome at different body sites in healthy humans. Next, we summarize nascent work on the origin of these populations, that is, the initial assembly of the human virome in neonates and infants after delivery. We then summarize data on interactions between the host and the virome, including links to disease states.

Human virome diversity

The number of bacterial cells associated with the human body is estimated to be roughly the same as the number of human cells, ~1013 in total20. One estimate suggests that each gram of metazoan tissue is associated, on average, with 3 × 109 bacteria21, and the complexity of these communities increases with body size22. VLP counts in humans reveal that the ratios between viruses and bacteria range from roughly 0.1 to 10, suggesting that the total number of viruses in the human body is of a similar order to the number of bacterial and human cells (reviewed in ref.10).

Viruses that are found in humans can be categorized by various features. Viral genomes can be either RNA or DNA, and either double-stranded or single-stranded. Genome sizes can be as low as a few kilobases or as large as hundreds of kilobases. All viruses have a protein shell (or capsid) surrounding the genome; viruses can also be enclosed in one or more lipid membranes. Viral particles can be classified according to their morphology — spherical (usually icosahedral), filamentous, bullet-shaped, pleomorphic or, for phages, tailed.

Most constituents of the human virome are inferred to be phages. This is an inference because, in most cases, the majority of sequences uncovered in a virome metagenomic sequencing experiment do not align with any information present in existing databases (Box 1), so it is unknown whether they are phages or some other virus types. The major taxa of phages are typically Caudovirales (tailed phages) and Microviridae (icosahedral non-tailed phages) of the group including phage ΦX174. Phages can have multiple relationships with their bacterial hosts, which constrain ideas about virome dynamics (Fig. 1). Lytic phages inject their nucleic acid into cells, leading to the synthesis of new viral components, the assembly of particles and the lysis of host cells, thus releasing progeny phages. Another mode of replication, carried out by temperate phages, can spare the host initially. Phages inject DNA into cells, after which the DNA can then become integrated into the host cell chromosome, forming a prophage. Prophages are maintained in a quiescent state by repressor proteins23. However, should conditions become unfavourable in the host cell — for example, by damage to DNA — phage DNA can become excised from the cellular chromosome leading to lytic growth, resulting in cell lysis and the production of viral progeny. Phages can also have other relationships with their hosts — one is pseudolysogeny, in which phage genomes persist as episomes without integration. In another mode, phages can bud out of infected cells, sparing the host cell from lysis and death.

Fig. 1: Phage replication cycles.

Phages can engage in four types of interactions with their hosts. In lytic growth, phages infect cells, produce viral macromolecules, assemble new particles and lyse host cells, thereby liberating new viral particles. In lysogenic growth, phages inject their genomes into cells, and the genomes then become integrated into the bacterial cellular chromosome. The prophage is maintained in a quiescent state until detection of a suitable induction signal, after which the phage genome becomes excised and goes on to direct lytic growth. Pseudolysogeny is a loose interaction between the phage and the host in which the phage genome is present in the bacterial cell but not actively directing lytic growth156. Lastly, some phages such as the filamentous phages (Inoviridae) can infect cells and preserve the infected cell while producing new phage progeny by budding.

Viruses that infect human cells are also an important part of the human virome. Some may cause acute infections, and others may establish long-term latency. Some viruses engage in benign colonization and cannot be associated with any particular disease, appearing to be long-term ‘passengers’ or ‘commensals’. Virome sequencing studies have unveiled some new lineages of human viruses that appear to be such commensals. For example, the Anelloviridae are a family of non-enveloped, single-stranded DNA viruses with quite small circular genomes (2–4 kb), including torque teno virus, torque teno mini virus and torque teno midi virus24,25,26. The genomes of viruses in this family encode what appears to be a single large protein, although gene expression has not been well studied because representative Anelloviridae have not yet been grown in pure culture. Anelloviridae are extremely diverse and can be found in many human body sites in a large fraction of all humans examined. No specific pathogenic effects have been linked to Anelloviridae so far (reviewed in refs27,28). Greater abundance of Anelloviridae has been found in individuals who are immunocompromised, including the recipients of lung transplants, individuals who are HIV positive and individuals on immunosuppressive medications owing to inflammatory bowel disease, indicating that Anelloviridae are normally under host immune control12,14,29,30,31. The newly discovered Redondoviridae are another family of small circular DNA viruses that appear to be widespread commensals commonly found in the respiratory tract32,33,34.

High inter-individual variation in the human virome has been reported in many studies (reviewed in refs9,10,35,36,37,38). However, within a healthy adult, the virome is usually relatively stable over time, paralleling stability in the cellular microbiome. For example, one study found that ~80% of viral contigs present persisted over a span of 2.5 years in the gut of one individual6. Another recent study tracked the gut virome of 10 individuals and found that >90% of recognizable viral contigs persisted in each individual over 1 year39. Studies on the oral virome revealed similar stability40,41. As discussed below, destabilization of the virome is often associated with disease states.

Virome of different body sites

Numerous recent studies have characterized the human virome at different body sites, revealing rich populations at numerous locations (Fig. 2). Phages are distributed widely across the human body, and different anatomical sites may have quite different phage composition due to the presence of different host bacteria. The distribution of eukaryotic viruses also differs at different body sites. Some notable site-specific features are summarized below.

Fig. 2: The human virome at different body sites.

Summary of viruses found at each human body site. Viral types are summarized from published virome surveys2,9,10,29,32,33,34,35,36,37,38,40,41,42,43,44,45,46,47,48,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,76,77,78; those known at each body site are likely to increase as more human populations are surveyed and more viral types are discovered. In a few cases, viral lineages were excluded from the analysis because they likely represent contaminants or misattributions. These exclusions include mimivirus, phycodnavirus, marseillevirus, flaviviruses and poxviruses in blood, and baculovirus in the vagina. VLP, virus-like particle.

Gastrointestinal tract

The gastrointestinal tract is commonly the most abundant site of viral colonization, reaching ~109 VLPs per gram of intestinal contents. Analysis of virome sequence data suggests that phages are the most abundant identifiable members of this population (reviewed in refs9,10,35,36,37,38). Visualization of stool VLPs using electron microscopy reveals that the majority of the phages belong to the order Caudovirales (tailed phages; reviewed in ref.10). Metagenomic sequencing of the human gut virome also indicated that Caudovirales is commonly predominant, along with the spherical Microviridae (reviewed in refs9,10,35,36,37,38).

It has been suggested that the most prevalent phage lineage in the human gut is often crAssphage (cross-assembly phage; members of the Caudovirales), specifically the short-tailed podoviruses, which infect bacteria of the phylum Bacteriodetes, common members of the gut microbiota42,43,44,45,46. crAssphages are commonly found in greater than 50% of human gut content samples and show a global distribution42,43,44. The abundance of crAssphages can be up to 90% of a human gut viral community42. Recently, the crAssphage ΦCrAss001 has been shown to infect Bacteroides intestinalis46, specifying one host species experimentally. Genomic analysis shows that phage genes important for lysogeny are rare or absent in crAssphage genomes45,46, and a lytic mode of replication has been suggested by infection studies in vitro46. However, curiously, proliferation of crAssphages does not appear to reduce the growth rate of their host cells in vitro46. One explanation is that crAssphages replicate via pseudolysogeny, in which the phage genome persists in a quiescent state as an episome (reviewed in ref.47), only rarely lysing the host cell.

The healthy human gut usually contains relatively low proportions of eukaryotic viruses. DNA viral lineages occasionally detected include Anelloviridae, Geminiviridae, Herpesviridae, Nanoviridae, Papillomaviridae, Parvoviridae, Polyomaviridae, Adenoviridae and Circoviridae (reviewed in ref.48). The most commonly detected RNA viruses include Caliciviridae, Picornaviridae, Reoviridae and some plant viruses that appear to originate in food, such as Virgaviridae2,12,49,50.

A notable pattern in viruses of the gut is that most residents, including both phages and human viruses, are not enveloped. This makes sense — lipid envelopes are unlikely to survive the detergent effects of bile salts, dehydration in the large intestine and the conditions of the environment outside the gut required for transmission via the faecal–oral route. A recent statistical analysis showed a significant association between faecal–oral transmission and the absence of a lipid envelope51. It will be of interest to investigate virus structure–transmission relationships in more detail and at additional human body sites.

Surprisingly, coronaviruses are an exception; despite possessing a lipid envelope, many coronaviruses are known to be transmitted via the faecal–oral route51. For severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), viral RNA has been widely reported in faeces, although the infectious potential of these viruses is uncertain52. One possible explanation is that coronaviruses such as SARS-CoV-2 can replicate in host cells of the lower gastrointestinal tract, so they do not need to traverse the entire gastrointestinal tract in order to appear in faeces; another possibility is that coronavirus particles are relatively stable for enveloped viruses. It will be useful to investigate these questions and clarify the infectivity of coronaviruses in faecal material systematically.

Oral cavity

The human oral cavity contains diverse viral communities as well as complex microbial populations. To date, saliva samples have been the primary source of material to characterize the oral virome40,53, revealing abundant viral populations. Additional oral microenvironments, such as dental plaque54, have also been studied, revealing high diversity in these environments as well. Staining of particles with a fluorescent dye that binds DNA, followed by visualization under a fluorescent microscope, shows approximately 108 VLPs per millilitre of saliva in healthy humans55. The most abundant taxon of phages in the oral virome is the Caudovirales40,41,56.

Common eukaryotic viruses in the oral cavity of healthy adults include Herpesviridae, Papillomaviridae, Anelloviridae and Redondoviridae32,57. Anelloviridae are the most common, but, surprisingly, the newly discovered Redondoviridae32 is the second most common virus family. However, it should be noted that prevalence measures are expected to be dependent on the sampling methods used, and the multiple displacement amplification steps typically used to amplify virome samples likely favour amplification of small DNA circles, potentially boosting detection of Anelloviridae and Redondoviridae. Reports so far put the prevalence of Redondoviridae at 2–15% in different populations32,33,34. As with Anelloviridae, whether Redondoviridae can cause disease is unknown. Preliminary studies show increased levels of redondoviruses in humans with periodontitis, patients who are critically ill in a medical intensive care unit and individuals with severe respiratory diseases32,33, although to date there is no evidence that redondoviruses are contributing to the disease states. Thus, both anelloviruses and redondoviruses appear to be common commensal viruses that might be undetected if not for developments in viral metagenomic sequencing methods.

Respiratory tract

Virome analyses have been performed on respiratory tract samples including sputum, nasopharyngeal swabs and bronchoalveolar lavage, showing that the healthy human lung and respiratory tract can be populated by large viral communities29,58,59,60,61,62. Among human DNA viruses, Anelloviridae has been reported to be the most prevalent family of DNA viruses, followed by Redondoviridae32. Additional eukaryotic viruses frequently detected include Adenoviridae, Herpesviridae and Papillomaviridae29,58,59,60,61,62. Phages are commonly found, including Caudovirales, Microviridae and Inoviridae29,58,59,60,61,62. Phages, like most of the cellular microbiota, even when found in the lung appear to be derived mainly from the abundant bacterial populations in the mouth and upper respiratory tract.


Viruses of blood have been studied closely, to understand human health and also to assess the safety of donor blood supplies. A pioneering study found viral particles in blood using electron microscopy and identified genomic sequences related to several eukaryotic viruses, including Anelloviridae63. Other recent studies have reported Herpesviridae, Marseilleviridae, Mimiviridae, Phycodnaviridae and Picornaviridae families, with proportions varying with the geographical site sampled64,65. Some of these findings illustrate the challenges of virome studies, where samples with low levels of authentic viruses may be prone to contamination (Box 1). It is important to note that Marseilleviridae, Mimiviridae and Phycodnaviridae are not known to replicate in human cells, and may represent environmental contamination. Phages belonging to the Myoviridae, Siphoviridae, Podoviridae, Microviridae and Inoviridae families have also been reported in blood, and, similarly, their origin is unclear (reviewed in refs48,66,67). Some of these studies did not perform viral particle enrichment prior to sequencing, so that prophage sequences integrated in bacterial genomes (rather than viral particles) may have been identified. A recent study reported that phage particles may be transported across gut epithelial cell layers by transcytosis, potentially reaching systemic circulation, with unknown consequences68. Thus, much remains to be learnt about the blood virome of healthy individuals; however, it does seem likely that at least Anelloviridae are common in blood and so must be expected to be present throughout the blood supply.


Compared with other body sites, the skin has a relatively low microbial biomass, which can, for some samples, make it difficult to distinguish the resident microbiome and virome from various forms of contamination. Metagenomic analysis of skin swabs revealed the presence of multiple eukaryotic virus families including Polyomaviridae, Papillomaviridae and Circoviridae69. In a recent DNA virome study with VLP enrichment70, ~95% of the viral sequences did not match a known viral genome and of the reads that could be assigned, many were associated with Caudovirales. This study also reported that the skin of healthy individuals harboured eukaryotic viruses including Adenoviridae, Anelloviridae, Circoviridae, Herpesviridae, Papillomaviridae and Polyomaviridae70. A notable expansion of these eukaryotic viruses was observed on the skin of individuals with primary immunodeficiencies, indicating the importance of immune surveillance in controlling viral colonization of the skin71.

Urogenital system

Urine samples from healthy humans have been reported to contain viruses in the region of 107 VLPs per millilitre72. Most of the identifiable viruses were phages; in addition, human papillomaviruses could be identified in >90% of subjects in some cohorts72,73. Virome analyses of healthy vaginal samples showed that the majority of identified viral sequences are derived from double-stranded DNA phages, with eukaryotic viruses contributing only 4% of total reads74. In seminal fluid, Anelloviridae, Herpesviridae and multiple genotypes of Papillomaviridae have been detected75. Thus, for these body sites we again see mixtures of viruses that replicate in human cells and viruses from the resident microbiota.

Nervous system

Little information is available on virome populations in the nervous system in healthy humans. A recent study estimated the VLP number at ~104 per millilitre of cerebrospinal fluid, with phages predominant, including Myoviridae, Siphoviridae and Podoviridae76. Herpesviridae were also detectable76. The clinical consequences of infection by herpesviruses in the nervous system have been well studied. Herpes simplex viruses, human cytomegalovirus and varicella zoster virus can establish latent infections in the central nervous system without symptoms77,78; these viruses can later be reactivated and produce viral particles78.

To summarize the virome over multiple human body sites, the human gut contains the most abundant viruses and has been the most frequently studied. Lower particle numbers are found at other body sites, but all seem to have detectable viral colonization. For sites with a resident microbiota, the viruses found are typically a mixture of viruses replicating in the local human cells and viruses infecting the local microbiota. The extent of circulation between sites is just starting to be assessed. Upper respiratory microbiota likely contribute much of the microbiome and virome to lower respiratory sites, at least for the phage population. Small circular DNA viruses (Anelloviridae and Redondoviridae) are common in respiratory samples and can also be found in faecal samples, although it is not known whether they appear in the gut because of replication in the gastrointestinal tract or swallowing of saliva. Anelloviridae but not Redondoviridae appear in blood, indicating systemic circulation. Even sites that are mostly cut off from normal microbial colonization, such as cerebrospinal fluid, show low levels of viruses including phages. How much of this colonization is due to true local viral replication, how much is due to systemic circulation of viruses and how much is due to technical mishaps associated with reagent contamination remains to be fully clarified. At all of these sites, unannotated ‘dark matter’ sequences are prominent, emphasizing how much remains to be learnt.

Establishment of the human virome

Timing of the first microbial colonization

The timing of virome establishment is linked to the question of establishment of the microbiome as a whole in human neonates and infants. Historically, the inability to culture microorganisms from samples from healthy deliveries has supported the idea that neonates are usually born sterile. Starting in 2014, several studies using metagenomic sequencing were carried out, leading to the proposal of a microbiome in the placenta, amniotic fluid and even the fetus, implying that microbial colonization may start in utero79,80,81,82,83. However, multiple recent studies have indicated that these detections of microorganisms are likely to be false positives due to experimental contamination, and that no placental microbiome is present before rupture of membranes and delivery84,85,86,87,88. This raises the question of when viral colonization takes place in human neonates. Vertical transmission of pathogenic viruses during pregnancy has been well documented for rubella virus, human cytomegalovirus, herpes simplex viruses, HIV, Zika virus and human papillomavirus (reviewed in refs89,90,91,92). However, these are characteristic of disease states and not health. Virome populations are robust in adults, so the question is when does the virome become established in healthy neonates.

The virome at delivery

An early study of virome colonization sampled meconium shortly after delivery, and failed to find VLPs using epifluorescent microscopy but did report ~108 VLPs per gram at 1 week of life, suggesting that the neonate lacked a virome at birth but was quickly colonized93. In a study of amniotic fluid, no evidence was found for the existence of a virome in healthy pregnancies before delivery86. A later study of neonate stool samples, investigating both RNA and DNA viromes, taken a median of 2.6 days after birth found high diversity in the gut virome, consistent with rapid colonization after delivery50. Another metagenomic study using stool samples collected a median of 37 h after birth again showed high viral diversity, supporting rapid virome acquisition94. A more recent study of VLPs sampled a median of 17 h after birth reported that only 15% of samples were positive49. Thus, the picture that emerges is that neonates usually lack a detectable virome at birth, but are rapidly colonized after rupture of membranes and delivery (Fig. 3).

Fig. 3: Stepwise assembly of the paediatric virome.

Healthy neonates are typically born lacking a gut virome or microbiome. Pioneering bacteria colonize the gut of the neonate, such that infants have a detectable microbiome by month 1 of life. These bacteria commonly harbour integrated prophages, which occasionally induce prophages, providing a first wave of viral particles in the gut. Later, by month 4, more viruses that infect human cells can be detected. Infection with these viruses, some of which can be pathogenic, is inhibited by breastfeeding. Breastfeeding can also alter the types of phages present by altering the proportions of bacteria in the infant gut, which consequently alters the proportions of their phages. The protective effects of breast milk can be conferred by maternal immune cells or various macromolecules. These include maternal antibodies, human milk oligosaccharides, lactoferrin, mucin and gangliosides. The viral groups targeted by each antiviral factor in human breast milk are shown. Supporting references include refs49,111,113,114,115,116,117,118,119,120,121,157. HSV, herpes simplex viruses; RSV, respiratory syncytial virus; SARS-CoV; severe acute respiratory syndrome coronavirus; VZV, varicella zoster virus.

The first detectable viruses — a predominance of phages

Several studies have investigated the nature of the human virome in samples taken very early in life. Recognizable early colonizers were mainly phages of the Siphoviridae, Podoviridae and Myoviridae families. Another phage family, the Microviridae, are less abundant during early life but rise in abundance with age49,50. Early bacterial colonizers commonly include Escherichia, Klebsiella, Enterococcus, Staphylococcus and Streptococcus species95,96, and the phages of these bacteria are some of the most common early virome members.

A recent study investigated the production of the virome in gut samples of infants at 1 month of life and concluded that lytic phages were relatively rare49. Ongoing replication of lytic phages could not be detected in direct infection assays; viral sequences were annotated primarily as lysogenic phages and not lytic phages; and Microviridae and crAssphages, which usually do not form lysogens, were rare or absent during the first month in infant guts. Instead, prophage induction was found to contribute most of the gut virome. Bacterial strains were isolated from infants’ stools, and many were found to produce viral particles at high levels. The viruses that were produced could be detected as prophage sequences in the bacterial genome sequences. Sequences of the induced phages were also commonly found in the infant stool virome, and the abundance of each type of VLP in stool was positively correlated with the abundance of the host bacteria in the same sample.

These experiments suggested a high rate of phage induction in the infant gut, raising the question of what constitutes the inducing signal. DNA damage is the most studied signal (reviewed in ref.97). In vitro studies suggested that spontaneous induction rates may be relatively low98,99. Bacterial metabolites, nutrients and bile salts have all been shown to induce prophages in some models100,101. Thus, the signals (if there are any) are unclear and an interesting topic for future studies.

Later evolution of the paediatric virome

The paediatric virome continues to mature with age. Lytic phages appear to become more common later in life. For example, the crAssphages are mostly absent in the first month of life but become more prominent by month 4 (ref.49). The gut virome also often undergoes a shift from Caudovirales-dominated to Microviridae-dominated12,50,102.

Another question is the possible influence of the mode of delivery. A metagenomic analysis of faecal virome samples from 20 infants at 1 year of age compared spontaneous vaginal delivery with caesarean section and found that the birth mode resulted in distinctly different viral communities, with infants born by spontaneous vaginal delivery having greater viral diversity103. The effect of the delivery mode has been reproduced in some, but not all, cohorts in other studies49. Studies linking the birth mode and long-term health outcomes reported greater risk for various diseases, including asthma, obesity and diabetes, in children delivered by caesarean section, although the results are controversial and research is ongoing104,105,106,107,108. It may be useful to consider possible influences of the virome as well.

Colonization of infants with viruses infecting human cells

The viruses that replicate in human cells are also detected in metagenomic surveys of samples taken in early life. Gastroenteritis is one of the leading causes of childhood mortality, resulting in more than two million deaths every year109, and viral pathogens are primary causes (reviewed in ref.110), highlighting the importance of paediatric virome studies. Viruses that have been reported to be associated with childhood diarrhoea include rotavirus, astrovirus, calicivirus, picornavirus, polyomavirus and adenovirus (reviewed in ref.110). Less well known is the fact that these viruses are commonly found in healthy infant guts in metagenomic studies49,50. Other common viruses in healthy infant guts include parvovirus and anellovirus49,50.

Thus, recent data suggest that healthy infants are colonized in a stepwise fashion. In the first step, prophage induction from pioneering bacteria provides an initial population. Later, lytic phages become more common, and also viruses that replicate in human cells.

Factors that shape the human virome

Numerous factors have been reported to influence the human virome and, ultimately, affect health (Fig. 4), starting in infancy and extending throughout the life of the individual.

Fig. 4: Factors that shape the human virome.

Major factors include the diet6, breast milk or formula feeding49,94, medications (including antibiotics and immunosuppressants)12,131, host genetics3,50,94,102,128,130, cohabitation53, geography49,65,131,132,133,134, presence of disease (Table 1) and ageing133.


The infant virome, including both phages and eukaryotic viruses, can be affected by diet. Breastfeeding is well established to reduce viral gastroenteritis and infant mortality (reviewed in refs111,112). A recent metagenomic virome study showed lower accumulation of animal cell viruses in guts of infants fed with breast milk49 (Fig. 3). The protective effect was seen in cohorts from both the United States and Botswana49. Viruses affected included Adenoviridae, Picornaviridae and Caliciviridae. Breast milk contains multiple components that protect children from intestinal infections, such as maternal antibodies, oligosaccharides and lactoferrin (reviewed in ref.111). These antiviral components have been reported to inhibit viruses, such as rotavirus, norovirus, enterovirus, influenza virus and SARS-CoV (reviewed in refs111,113,114,115,116,117,118,119,120,121). The phage population structure in infant stool can also be influenced by breastfeeding — specific bacteria are known to increase in abundance with breastfeeding, and in a recent report their phages were increased in abundance as well49. Alterations of the viral population in infant stool samples owing to breastfeeding has been proposed in another study, although the small sample size was a limitation94. Furthermore, it has been suggested that the infant virome may, in fact, be at least partially transmitted from the mother via breast milk122,123.

Diet has also been reported to affect the virome in adults. For example, comparison of the virome structure in adult subjects on two different controlled diets showed that individuals on the same diet showed more similar viral compositions than those on different diets6.

Host genetics and immunity

Intense interest has focused on the potential influence of human genetics on the microbiome, raising the linked question of the role of human genetics in programming the virome. Several studies of twins, comparing monozygotic and dizygotic twin pairs, have suggested an influence of human genetics on microbiome composition because the monozygotic twins showed more similarity124,125,126. By contrast, a recent large-scale study of healthy adults (non-twins) reported little effect of genetics and emphasized environmental factors127. In studies of the infant virome, the gut virome compositions of co-twins were more similar than those between unrelated individuals50,94,102, but this similarity was not strongly affected by zygosity94,102, emphasizing the importance of the shared environment over human genetic composition. In an early study of adult twins, no greater similarity of virome samples was seen in twin pairs3. In a more recent study with a larger cohort of adult monozygotic twins, some were found to have greater similarity in virome composition compared with unrelated individuals, but in other co-twin pairs the microbiota and the virome had diverged to the degree that the twins were no longer notably similar128. Collectively, studies of the gut virome in twin pairs so far show similarities early in life, but not stronger similarities in monozygotic twins versus dizygotic twins, thus emphasizing the importance of shared environmental factors in colonization versus contributions of genetic make-up.

However, in inherited diseases such as primary immunodeficiencies, the effects of genetics on the virome are well established. In some cases, phenotypes of mutations in human genes can only be understood by considering the interaction with the virome. One drastic example involves epidermodysplasia verruciformis (also known as treeman syndrome, which is a rare heritable skin disease). In the presence of a mutation in TMC6 (EVER1) or TMC8 (EVER2), skin papillomaviruses replicate aggressively and cause massive inappropriate outgrowth of skin cells, resulting in treeman syndrome (reviewed in ref.129). Other primary immunodeficiencies may similarly allow specific viruses or microorganisms to replicate unchecked, resulting in distinctive disorders. The effects of immunodeficiencies on the skin virome were mentioned above; also, virome studies of individuals undergoing treatment for X-linked severe combined immunodeficiency (SCID-X1) revealed distinctive outgrowths of several viral lineages in the gut130. An interesting question for future investigation is how much of the phenotypes of diverse human genetic diseases are a result of altered interactions with the normal virome.

Geography and stochastics of colonization

Large-scale virome studies have provided evidence that geographic location and stochastics of colonization have strong impacts on human virome variation. A study of human faecal samples from different regions within China reported variation of the phage population structure and found that geography had the strongest impact compared with other variables, including diet, ethnicity and medication131. Geography has been associated with the eukaryotic virus populations as well. An early study found geographic variation in eukaryotic viromes in children with diarrhoea from two locations within Australia, with differential prevalence of Adenoviridae and Picornaviridae132. A blood virome analysis of eukaryotic viruses in a Chinese population revealed a distinctive pattern for people living in the southern part of China65. Moreover, one study of the infant virome found a higher prevalence of viruses infecting human cells in cohorts of people of African descent than in cohorts from the United States49. A recent study collected public metagenomic data sets and built a virome database with >30,000 viral genomes, and found higher viral diversity in populations from non-western countries compared with populations from western countries133. Similar results were reported in another study134. Thus, effects of geography are quite prominent.

Additional factors

Additional factors have been tested and reported to influence the human virome. One study tested age using public data, and found that viral diversities in early life and in older individuals (>65 years of age) are lower than those in healthy adults (18–65 years of age), indicating another dimension of age-dependent patterns133. Effects of ethnicity and medication were also found in a large Chinese cohort131. Cohabitation is also a factor — in an early study, members of the same household shared more similarity in the oral virome compared with those from different households53, suggesting transmission of the virome via close contact.

Thus, nascent studies of factors affecting the virome highlight diet, geography, age and health status as major correlates of virome structure. Genetics is less clear, at least in studies so far of healthy twins. More studies of large cohorts with linked comprehensive metadata will be helpful going forward.

The virome in health and disease

Virome populations can influence their human hosts in numerous ways. Eukaryotic viruses that infect human cells establish infections, trigger immune responses and, sometimes, cause diseases. Phages can affect the host indirectly via modulating of bacterial composition and bacterial fitness. Some phages and human cell viruses can be integrated into cells of their respective hosts, on occasion transferring new functionality to host cells. Some phages may also interact with human cells directly and trigger immune responses (Fig. 5). Recent examples of host–virome interactions in health and disease are discussed below (for reviews, see refs135,136).

Fig. 5: Host–virome interactions.

Eukaryotic viruses have both detrimental (red arrow) and beneficial (blue arrow) effects on host health. Phages interact with the host directly or indirectly via the host-associated bacterial community and pose undetermined effects (green arrow) on host health. Data based on refs68,137,138,139,140,141,142,143,144,149,150,151. TLR, Toll-like receptor.

Interactions between bacteria, phage and their human hosts

Relatively little is known about the impact of phage predation on human bacterial communities. A window on phage predation and host health is provided by phage therapy, in which phages are deliberately applied to human individuals to treat bacterial infections. As more drug-resistant bacteria are emerging, there is increased interest in this approach (reviewed in ref.137). Recently, several studies have used phage cocktails to treat bacterial infection in a few individuals, with apparent success (reviewed in ref.138) motivating larger clinical trials. Evidence that the phages are in fact creating evolutionary pressure on pathogenic bacteria in these studies comes from the observation that bacteria often mutated to become resistant to the therapeutic phage. Phages may even be useful to treat additional diseases. For example, a phage cocktail targeting adherent invasive Escherichia coli strains has been suggested recently as a treatment for Crohn’s disease139.

Phages can move DNA between cells and, thereby, introduce new functionality to bacterial genomes, which may modify bacterial fitness and virulence (reviewed in ref.140). In a recent study using a mouse model, the stool virome was analysed after antibiotic treatment, showing that there was an enrichment of phage-encoded genes for antibiotic resistance141, which increased resistance in the bacterial community.

Prophage induction can also lead to bacterial cell lysis, regulating bacterial abundance. A recent publication investigated diet-mediated prophage induction of human-associated bacterial strains in vitro, revealing that several common food compounds can inhibit bacterial growth by inducing prophages, including artificial sweeteners142.

Recent in vitro and animal studies indicated that phages may interact with the host immune system directly. Phages may be taken up by immune cells and trigger immune responses, without the mediation of bacteria, via Toll-like receptor (TLR) signalling. A recent publication reported that phages produced by pathogenic bacteria can be taken up by immune cells (dendritic cells, B cells and monocytes) in mice to induce type I interferon responses via TLR3 signalling143. Another study showed that interferon-γ (IFNγ)-producing CD4+ T cells and CD8+ T cells were increased in mucosal sites in germ-free mice fed an E. coli phage isolated from the human gut144. Furthermore, this study also revealed that Lactobacillus, Escherichia and Bacteroides phages can stimulate the production of IL-12, IL-6, IL-10 and IFNγ via the nucleotide-sensing receptor TLR9 (ref.144). Collectively, the interactions among phages, bacteria and the host immune system likely have important roles in host immune homeostasis.

Human disease-associated virome signatures

Studies of interactions between the virome with human diseases are just starting. Of course, numerous individual viruses are well known to cause morbidity and mortality. Studies of whole viral populations have now also begun to show patterns associated with disease states. Some recent examples are described below.

The virome has been considered to be a potential trigger of autoimmune diseases. In one study, changes in viral populations were both directly and inversely associated with the development of paediatric type 1 diabetes16. Virome signatures have been associated with paediatric and adult inflammatory bowel disease in several studies11,12,13,14,15, including a reproducible expansion of Caudovirales and a reduction of Microviridae. Whether this is a consequence of altered dysbiotic bacterial populations or is more deeply involved in the disease process remains to be clarified. A metagenomic study showed that children with frequent exposure to enterovirus between 1 and 2 years of age have a higher risk of coeliac disease145. Recent studies revealed that the relationships between phages and bacterial populations may influence growth stunting in children146,147. Examples of proposed associations between diseases and viral population structure are listed in Table 1.

Studies using animal models have indicated that some eukaryotic viruses may even be beneficial to the host (reviewed in refs135,148). For example, persistent infection by a strain of murine norovirus can compensate for the absence of bacteria in gnotobiotic mice, allowing restoration of intestinal morphology and promoting lymphocyte differentiation149. Murine astrovirus protected immunodeficient mice from enteric norovirus infections through the induction of type III interferons in the intestinal epithelial barrier150. Depletion of murine gut viruses using an antiviral cocktail inhibited the development of the intestinal intraepithelial lymphocytes, at least in part151. So far, all of these studies showing positive effects were performed in model organisms — it will be of interest to determine how much beneficial immune instruction may be directed by the virome in humans.

Thus, both phages and eukaryotic viruses can promote host health through interactions with the host immune system. However, virome studies using human cohorts suggest that dysbiosis of the virome is associated with multiple diseases. These studies emphasize the balance between beneficial and harmful roles of viral populations in humans and other organisms.

Conclusions and perspectives

The virome field has come a long way since the first paper in 2002 that reported metagenomic sequencing of a viral specimen. The methods for study have advanced, although there are still many challenges associated with working with metagenomic dark matter. Human virome population diversity and composition is being documented for many body sites — one consistent conclusion is that each individual harbours diverse and distinctive viral communities. Future studies are needed to clarify the DNA and RNA viromes at different anatomical sites and to link the alterations of viral composition to specific diseases. We now have a detailed picture of the stepwise nature of the assembly of the human virome after birth. The impact of viral colonization during early life on long-term health outcomes is still unknown and warrants careful study. Breastfeeding appears to have an important role during viral colonization; how the antiviral components in breast milk interact with the different components of the virome warrants further investigation. Emerging data indicate that factors that influence the human microbiome also often influence the virome as well, so that sorting out the influence of each will be a challenge going forward. Resident viruses are not only actively interacting with other microorganisms but also with the mammalian immune system. Many intriguing conclusions have so far only been obtained in animal studies or in vitro experiments, focusing attention on translation to studies in humans. Associations between alterations of virome and disease states are being identified more commonly, but in many cases causality and molecular mechanisms remain to be worked out. The vast world of the human virome is beginning to be understood, laying the ground work for numerous future studies of its importance.


  1. 1.

    Breitbart, M. et al. Metagenomic analyses of an uncultured viral community from human feces. J. Bacteriol. 185, 6220–6223 (2003).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  2. 2.

    Zhang, T. et al. RNA viral community in human feces: prevalence of a pathogenic viruses. PLoS Biol. 4, 0108–0118 (2006).

    CAS  Article  Google Scholar 

  3. 3.

    Reyes, A. et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 466, 334–338 (2010).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  4. 4.

    Minot, S. et al. Rapid evolution of the human gut virome. Proc. Natl Acad. Sci. USA 110, 12450–12455 (2013).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  5. 5.

    Minot, S., Wu, G. D., Lewis, J. D. & Bushman, F. D. Conservation of gene cassettes among diverse viruses of the human gut. PLoS ONE 7, e42342 (2012).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  6. 6.

    Minot, S. et al. The human gut virome: inter-individual variation and dynamic response to diet. Genome Res. 21, 1616–1625 (2011).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  7. 7.

    Minot, S., Grunberg, S., Wu, G. D., Lewis, J. D. & Bushman, F. D. Hypervariable loci in the human gut virome. Proc. Natl Acad. Sci. USA 109, 3962–3966 (2012).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  8. 8.

    Breitbart, M. et al. Genomic analysis of uncultured marine viral communities. Proc. Natl Acad. Sci. USA 99, 14250–14255 (2002).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  9. 9.

    Aggarwala, V., Liang, G. & Bushman, F. D. Viral communities of the human gut: metagenomic analysis of composition and dynamics. Mob. DNA 8, 12 (2017).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  10. 10.

    Shkoporov, A. N. & Hill, C. Bacteriophages of the human gut: the “known knknown” of the microbiome. Cell Host Microbe 25, 195–209 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  11. 11.

    Fernandes, M. A. et al. Enteric virome and bacterial microbiota in children with ulcerative colitis and Crohn disease. J. Pediatr. Gastroenterol. Nutr. 68, 30–36 (2019).

    PubMed  PubMed Central  Article  Google Scholar 

  12. 12.

    Liang, G. et al. Dynamics of the stool virome in very early-onset inflammatory bowel disease. J. Crohn’s Colitis 14, 1600–1610 (2020).

    CAS  Article  Google Scholar 

  13. 13.

    Clooney, A. G. et al. Whole-virome analysis sheds light on viral dark matter in inflammatory bowel disease. Cell Host Microbe 26, 764–778.e5 (2019).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  14. 14.

    Norman, J. M. et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160, 447–460 (2015).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  15. 15.

    Zuo, T. et al. Gut mucosal virome alterations in ulcerative colitis. Gut 68, 1169–1179 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  16. 16.

    Zhao, G. et al. Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children. Proc. Natl Acad. Sci. USA 114, E6166–E6175 (2017).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  17. 17.

    Kim, K. W. et al. Distinct gut virome profile of pregnant women with type 1 diabetes in the ENDIA study. Open Forum Infect. Dis. 6, ofz025 (2019).

    Article  CAS  Google Scholar 

  18. 18.

    Han, M., Yang, P., Zhong, C. & Ning, K. The human gut virome in hypertension. Front. Microbiol. 9, 3150 (2018).

    PubMed  PubMed Central  Article  Google Scholar 

  19. 19.

    Nakatsu, G. et al. Alterations in enteric virome are associated with colorectal cancer and survival outcomes. Gastroenterology 155, 529–541.e5 (2018).

    PubMed  Article  PubMed Central  Google Scholar 

  20. 20.

    Sender, R., Fuchs, S. & Milo, R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14, 1–14 (2016).

    Article  CAS  Google Scholar 

  21. 21.

    Kieft, T. L. & Simmons, K. A. Allometry of animal–microbe interactions and global census of animal-associated microbes. Proc. Royal. Soc. B. 282, 20150702 (2015).

    Article  Google Scholar 

  22. 22.

    Sherrill-Mix, S. et al. Allometry and ecology of the bilaterian gut microbiome. mBio 9, e00319-18 (2018).

    PubMed  PubMed Central  Article  Google Scholar 

  23. 23.

    Jacob, F., Sussman, R. & Monod, J. On the nature of the repressor ensuring the immunity of lysogenic bacteria [French]. C. R. Acad. Sci. 254, 4214–4216 (1962).

    CAS  Google Scholar 

  24. 24.

    Nishizawa, T. et al. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem. Biophys. Res. Commun. 241, 92–97 (1997).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  25. 25.

    Takahashi, K., Iwasa, Y., Hijikata, M. & Mishiro, S. Identification of a new human DNA virus (TTV-like mini virus, TLMV) intermediately related to TT virus and chicken anemia virus. Arch. Virol. 145, 979–993 (2000).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  26. 26.

    Ninomiya, M. et al. Identification and genomic characterization of a novel human torque teno virus of 3.2 kb. J. Gen. Virol. 88, 1939–1944 (2007).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  27. 27.

    Freer, G. et al. The virome and its major component, anellovirus, a convoluted system molding human immune defenses and possibly affecting the development of asthma and respiratory diseases in childhood. Front. Microbiol. 9, 686 (2018).

    PubMed  PubMed Central  Article  Google Scholar 

  28. 28.

    Spandole, S., Cimponeriu, D., Berca, L. M. & Mihăescu, G. Human anelloviruses: an update of molecular, epidemiological and clinical aspects. Arch. Virol. 160, 893–908 (2015).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  29. 29.

    Young, J. C. et al. Viral metagenomics reveal blooms of anelloviruses in the respiratory tract of lung transplant recipients. Am. J. Transpl. 15, 200–209 (2015).

    CAS  Article  Google Scholar 

  30. 30.

    Monaco, C. L. et al. Altered virome and bacterial microbiome in human immunodeficiency virus-associated acquired immunodeficiency syndrome. Cell Host Microbe 19, 311–322 (2016).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  31. 31.

    Li, L. et al. AIDS alters the commensal plasma virome. J. Virol. 87, 10912–10915 (2013).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  32. 32.

    Abbas, A. A. et al. Redondoviridae, a family of small, circular DNA viruses of the human oro-respiratory tract associated with periodontitis and critical Illness. Cell Host Microbe 25, 719–729.e4 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  33. 33.

    Spezia, P. G. et al. Redondovirus DNA in human respiratory samples. J. Clin. Virol. 131, 104586 (2020).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  34. 34.

    Lázaro-Perona, F. et al. Metagenomic detection of two vientoviruses in a human sputum sample. Viruses 12, 327 (2020).

    PubMed Central  Article  CAS  Google Scholar 

  35. 35.

    Mirzaei, M. K. & Maurice, C. F. Ménage à trois in the human gut: interactions between host, bacteria and phages. Nat. Rev. Microbiol. 15, 397–408 (2017).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  36. 36.

    Lim, E. S., Wang, D. & Holtz, L. R. The bacterial microbiome and virome milestones of infant development. Trends Microbiol. 24, 801–810 (2016).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  37. 37.

    Virgin, H. W. The virome in mammalian physiology and disease. Cell 157, 142–150 (2014).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  38. 38.

    Reyes, A., Semenkovich, N. P., Whiteson, K., Rohwer, F. & Gordon, J. I. Going viral: next-generation sequencing applied to phage populations in the human gut. Nat. Rev. Microbiol. 10, 607–617 (2012).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  39. 39.

    Shkoporov, A. N. et al. The human gut virome is highly diverse, stable, and individual specific. Cell Host Microbe 26, 527–541.e5 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  40. 40.

    Abeles, S. R. et al. Human oral viruses are personal, persistent and gender-consistent. ISME J. 8, 1753–1767 (2014).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  41. 41.

    Abeles, S. R., Ly, M., Santiago-Rodriguez, T. M. & Pride, D. T. Effects of long term antibiotic therapy on human oral and fecal viromes. PLoS ONE 10, e0134941 (2015).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  42. 42.

    Dutilh, B. E. et al. A highly abundant bacteriophage discovered in the unknown sequences of human faecal metagenomes. Nat. Commun. 5, 1–11 (2014).

    Article  CAS  Google Scholar 

  43. 43.

    Guerin, E. et al. Biology and taxonomy of crAss-like bacteriophages, the most abundant virus in the human gut. Cell Host Microbe 24, 653–664.e6 (2018).

    CAS  PubMed  Article  Google Scholar 

  44. 44.

    Edwards, R. A. et al. Global phylogeography and ancient evolution of the widespread human gut virus crAssphage. Nat. Microbiol. 4, 1727–1736 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  45. 45.

    Yutin, N. et al. Discovery of an expansive bacteriophage family that includes the most abundant viruses from the human gut. Nat. Microbiol. 3, 38–46 (2018).

    CAS  PubMed  Article  Google Scholar 

  46. 46.

    Shkoporov, A. N. et al. ΦCrAss001 represents the most abundant bacteriophage family in the human gut and infects Bacteroides intestinalis. Nat. Commun. 9, 1–8 (2018).

    CAS  Article  Google Scholar 

  47. 47.

    Sutton, T. D. S. & Hill, C. Gut bacteriophage: current understanding and challenges. Front. Endocrinol. 10, 784 (2019).

    Article  Google Scholar 

  48. 48.

    Rascovan, N., Duraisamy, R. & Desnues, C. Metagenomics and the human virome in asymptomatic individuals. Annu. Rev. Microbiol. 70, 125–141 (2016).

    CAS  PubMed  Article  Google Scholar 

  49. 49.

    Liang, G. et al. The stepwise assembly of the neonatal virome is modulated by breastfeeding. Nature 581, 470–474 (2020).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  50. 50.

    Lim, E. S. et al. Early life dynamics of the human gut virome and bacterial microbiome in infants. Nat. Med. 21, 1228–1234 (2015).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  51. 51.

    Bushman, F. D., McCormick, K. & Sherrill-Mix, S. Virus structures constrain transmission modes. Nat. Microbiol. 4, 1778–1780 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  52. 52.

    Zapor, M. Persistent detection and infectious potential of SARS-CoV-2 virus in clinical specimens from COVID-19 patients. Viruses 12, 1384 (2020).

    CAS  PubMed Central  Article  Google Scholar 

  53. 53.

    Robles-Sikisaka, R. et al. Association between living environment and human oral viral ecology. ISME J. 7, 1710–1724 (2013).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  54. 54.

    Naidu, M., Robles-Sikisaka, R., Abeles, S. R., Boehm, T. K. & Pride, D. T. Characterization of bacteriophage communities and CRISPR profiles from dental plaque. BMC Microbiol. 14, 1–13 (2014).

    Article  Google Scholar 

  55. 55.

    Pride, D. T. et al. Evidence of a robust resident bacteriophage population revealed through analysis of the human salivary virome. ISME J. 6, 915–926 (2012).

    CAS  PubMed  Article  Google Scholar 

  56. 56.

    Pérez-Brocal, V. & Moya, A. The analysis of the oral DNA virome reveals which viruses are widespread and rare among healthy young adults in Valencia (Spain). PLoS ONE 13, e0191867 (2018).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  57. 57.

    Baker, J. L., Bor, B., Agnello, M., Shi, W. & He, X. Ecology of the oral microbiome: beyond bacteria. Trends Microbiol. 25, 362–374 (2017).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  58. 58.

    Willner, D. et al. Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals. PLoS ONE 4, e7370 (2009).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  59. 59.

    Wylie, K. M., Mihindukulasuriya, K. A., Sodergren, E., Weinstock, G. M. & Storch, G. A. Sequence analysis of the human virome in febrile and afebrile children. PLoS ONE 7, e27735 (2012).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  60. 60.

    Clarke, E. L. et al. Microbial lineages in sarcoidosis a metagenomic analysis tailored for low-microbial content samples. Am. J. Respir. Crit. Care Med. 197, 225–234 (2018).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  61. 61.

    Abbas, A. A. et al. The perioperative lung transplant virome: torque teno viruses are elevated in donor lungs and show divergent dynamics in primary graft dysfunction. Am. J. Transplant. 17, 1313–1324 (2017).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  62. 62.

    Abbas, A. A. et al. Bidirectional transfer of Anelloviridae lineages between graft and host during lung transplantation. Am. J. Transplant. 19, 1086–1097 (2019).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  63. 63.

    Breitbart, M. & Rohwer, F. Method for discovering novel DNA viruses in blood using viral particle selection and shotgun sequencing. Biotechniques 39, 729–736 (2005).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  64. 64.

    Moustafa, A. et al. The blood DNA virome in 8,000 humans. PLoS Pathog. 13, e1006292 (2017).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  65. 65.

    Liu, S. et al. Genomic analyses from non-invasive prenatal testing reveal genetic associations, patterns of viral infections, and Chinese population history. Cell 175, 347–359.e14 (2018).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  66. 66.

    Castillo, D. J., Rifkin, R. F., Cowan, D. A. & Potgieter, M. The healthy human blood microbiome: fact or fiction? Front. Cell. Infect. Microbiol. 9, 148 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  67. 67.

    Zárate, S., Taboada, B., Yocupicio-Monroy, M. & Arias, C. F. Human virome. Arch. Med. Res. 48, 701–716 (2017).

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  68. 68.

    Nguyen, S. et al. Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers. mBio 8, 1874–1891 (2017).

    Google Scholar 

  69. 69.

    Foulongne, V. et al. Human skin microbiota: high diversity of DNA viruses identified on the human skin by high throughput sequencing. PLoS ONE 7, e38499 (2012).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  70. 70.

    Hannigan, G. D. et al. The human skin double-stranded DNA virome: topographical and temporal diversity, genetic enrichment, and dynamic associations with the host microbiome. mBio 6, e01578-15 (2015).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  71. 71.

    Tirosh, O. et al. Expanded skin virome in DOCK8-deficient patients. Nat. Med. 24, 1815–1821 (2018).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  72. 72.

    Santiago-Rodriguez, T. M., Ly, M., Bonilla, N. & Pride, D. T. The human urine virome in association with urinary tract infections. Front. Microbiol. 6, 14 (2015).

    PubMed  PubMed Central  Google Scholar 

  73. 73.

    Garretto, A., Miller-Ensminger, T., Wolfe, A. J. & Putonti, C. Bacteriophages of the lower urinary tract. Nat. Rev. Urol. 16, 422–432 (2019).

    PubMed  PubMed Central  Article  Google Scholar 

  74. 74.

    Jakobsen, R. R. et al. Characterization of the vaginal DNA virome in health and dysbiosis. Viruses 12, 1143 (2020).

    CAS  PubMed Central  Article  Google Scholar 

  75. 75.

    Li, Y. et al. Semen virome of men with HIV on or off antiretroviral treatment. AIDS 34, 827–832 (2020).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  76. 76.

    Ghose, C. et al. The virome of cerebrospinal fluid: viruses where we once thought there were none. Front. Microbiol. 10, 2061 (2019).

    PubMed  PubMed Central  Article  Google Scholar 

  77. 77.

    Meyding Lamade, U. & Strank, C. Herpesvirus infections of the central nervous system in immunocompromised patients. Ther. Adv. Neurol. Disord. 5, 279–296 (2012).

    PubMed  PubMed Central  Article  Google Scholar 

  78. 78.

    McGavern, D. B. & Kang, S. S. Illuminating viral infections in the nervous system. Nat. Rev. Immunol. 11, 318–329 (2011).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  79. 79.

    Aagaard, K. et al. The placenta harbors a unique microbiome. Sci. Transl Med. 6, 237ra65 (2014).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  80. 80.

    Antony, K. M. et al. The preterm placental microbiome varies in association with excess maternal gestational weight gain. Am. J. Obstet. Gynecol. 212, 653.e1–653.e16 (2015).

    Article  Google Scholar 

  81. 81.

    Prince, A. L. et al. The placental membrane microbiome is altered among subjects with spontaneous preterm birth with and without chorioamnionitis. Am. J. Obstet. Gynecol. 214, 627.e1–627.e16 (2016).

    Article  Google Scholar 

  82. 82.

    Collado, M. C., Rautava, S., Aakko, J., Isolauri, E. & Salminen, S. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci. Rep. 6, 1–13 (2016).

    Article  CAS  Google Scholar 

  83. 83.

    Martinez, K. A. et al. Bacterial DNA is present in the fetal intestine and overlaps with that in the placenta in mice. PLoS ONE 13, e0197439 (2018).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  84. 84.

    Theis, K. R. et al. Does the human placenta delivered at term have a microbiota? Results of cultivation, quantitative real-time PCR, 16S rRNA gene sequencing, and metagenomics. Am. J. Obs. Gynecol. 220, 267.e1–267.e39 (2019).

    CAS  Article  Google Scholar 

  85. 85.

    Lauder, A. P. et al. Comparison of placenta samples with contamination controls does not provide evidence for a distinct placenta microbiota. Microbiome 4, 29 (2016).

    PubMed  PubMed Central  Article  Google Scholar 

  86. 86.

    Lim, E. S., Rodriguez, C. & Holtz, L. R. Amniotic fluid from healthy term pregnancies does not harbor a detectable microbial community. Microbiome 6, 87 (2018).

    PubMed  PubMed Central  Article  Google Scholar 

  87. 87.

    Leiby, J. S. et al. Lack of detection of a human placenta microbiome in samples from preterm and term deliveries. Microbiome 6, 196 (2018).

    PubMed  PubMed Central  Article  Google Scholar 

  88. 88.

    de Goffau, M. C. et al. Human placenta has no microbiome but can contain potential pathogens. Nature 572, 329–334 (2019).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  89. 89.

    Epps, R. E., Pittelkow, M. R. & Daniel Su, W. P. TORCh syndrome. Semin. Cutan. Med. Surg. 14, 179–186 (1995).

    CAS  Google Scholar 

  90. 90.

    Leeper, C. & Lutzkanin, A. Infections during pregnancy. Prim. Care 45, 567–586 (2018).

    PubMed  Article  PubMed Central  Google Scholar 

  91. 91.

    Carlson, A., Norwitz, E. R. & Stiller, R. J. Cytomegalovirus infection in pregnancy: should all women be screened? Rev. Obstet. Gynecol. 3, 172–179 (2010).

    PubMed  PubMed Central  Google Scholar 

  92. 92.

    Arora, N., Sadovsky, Y., Dermody, T. S. & Coyne, C. B. Microbial vertical transmission during human pregnancy. Cell Host Microbe 21, 561–567 (2017).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  93. 93.

    Breitbart, M. et al. Viral diversity and dynamics in an infant gut. Res. Microbiol. 159, 367–373 (2008).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  94. 94.

    Maqsood, R. et al. Discordant transmission of bacteria and viruses from mothers to babies at birth. Microbiome 7, 156 (2019).

    PubMed  PubMed Central  Article  Google Scholar 

  95. 95.

    Bäckhed, F. et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17, 690–703 (2015).

    Article  CAS  Google Scholar 

  96. 96.

    Baumann-Dudenhoeffer, A. M., D’Souza, A. W., Tarr, P. I., Warner, B. B. & Dantas, G. Infant diet and maternal gestational weight gain predict early metabolic maturation of gut microbiomes. Nat. Med. 24, 1822–1829 (2018).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  97. 97.

    Sausset, R., Petit, M. A., Gaboriau-Routhiau, V. & De Paepe, M. New insights into intestinal phages. Mucosal Immunol. 13, 205–215 (2020).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  98. 98.

    Nanda, A. M., Thormann, K. & Frunzke, J. Impact of spontaneous prophage induction on the fitness of bacterial populations and host–microbe interactions. J. Bacteriol. 197, 410–419 (2015).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  99. 99.

    Cortes, M. G., Krog, J. & Balázsi, G. Optimality of the spontaneous prophage induction rate. J. Theor. Biol. 483, 110005 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  100. 100.

    Jubelin, G. et al. Modulation of enterohaemorrhagic Escherichia coli survival and virulence in the human gastrointestinal tract. Microorganisms 6, 115 (2018).

    CAS  PubMed Central  Article  Google Scholar 

  101. 101.

    De Paepe, M. et al. Carriage of λ latent virus is costly for its bacterial host due to frequent reactivation in monoxenic mouse intestine. PLOS Genet. 12, e1005861 (2016).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  102. 102.

    Reyes, A. et al. Gut DNA viromes of Malawian twins discordant for severe acute malnutrition. Proc. Natl Acad. Sci. USA 112, 11941–11946 (2015).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  103. 103.

    McCann, A. et al. Viromes of one year old infants reveal the impact of birth mode on microbiome diversity. PeerJ 6, e4694 (2018).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  104. 104.

    Black, M., Bhattacharya, S., Philip, S., Norman, J. E. & McLernon, D. J. Planned cesarean delivery at term and adverse outcomes in childhood health. J. Am. Med. Assoc. 314, 2271–2279 (2015).

    CAS  Article  Google Scholar 

  105. 105.

    Kuhle, S., Tong, O. S. & Woolcott, C. G. Association between caesarean section and childhood obesity: a systematic review and meta-analysis. Obes. Rev. 16, 295–303 (2015).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  106. 106.

    Adlercreutz, E. H., Wingren, C. J., Vincente, R. P., Merlo, J. & Agardh, D. Perinatal risk factors increase the risk of being affected by both type 1 diabetes and coeliac disease. Acta Paediatr. 104, 178–184 (2015).

    PubMed  Article  PubMed Central  Google Scholar 

  107. 107.

    Rutayisire, E., Huang, K., Liu, Y. & Tao, F. The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants’ life: a systematic review. BMC Gastroenterol. 16, 86 (2016).

    PubMed  PubMed Central  Article  Google Scholar 

  108. 108.

    Neu, J. & Rushing, J. Cesarean versus vaginal delivery: long-term infant outcomes and the hygiene hypothesis. Clin. Perinatol. 38, 321–331 (2011).

    PubMed  PubMed Central  Article  Google Scholar 

  109. 109.

    Hug, L., Alexander, M., You, D. & Alkema, L. National, regional, and global levels and trends in neonatal mortality between 1990 and 2017, with scenario-based projections to 2030: a systematic analysis. Lancet Glob. Heal. 7, e710–e720 (2019).

    Article  Google Scholar 

  110. 110.

    Oude Munnink, B. B., Hoek, L. & van der Hoek, L. Viruses causing gastroenteritis: the known, the new and those beyond. Viruses 8, 42 (2016).

    PubMed Central  Article  CAS  Google Scholar 

  111. 111.

    Turin, C. G. & Ochoa, T. J. The role of maternal breast milk in preventing infantile diarrhea in the developing world. Curr. Trop. Med. Rep. 1, 97–105 (2014).

    PubMed  PubMed Central  Google Scholar 

  112. 112.

    Lamberti, L. M., Fischer Walker, C. L., Noiman, A., Victora, C. & Black, R. E. Breastfeeding and the risk for diarrhea morbidity and mortality. BMC Public Health 11, S15 (2011).

    PubMed  PubMed Central  Article  Google Scholar 

  113. 113.

    Wakabayashi, H., Oda, H., Yamauchi, K. & Abe, F. Lactoferrin for prevention of common viral infections. J. Infect. Chemother. 20, 666–671 (2014).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  114. 114.

    Lang, J. et al. Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. PLoS ONE 6, e23710 (2011).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  115. 115.

    Witkowska-Zimny, M. & Kaminska-El-Hassan, E. Cells of human breast milk. Cell. Mol. Biol. Lett. 22, 11 (2017).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  116. 116.

    Simister, N. E. Placental transport of immunoglobulin G. Vaccine 21, 3365–3369 (2003).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  117. 117.

    Pou, C. et al. The repertoire of maternal anti-viral antibodies in human newborns. Nat. Med. 25, 591–596 (2019).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  118. 118.

    Albrecht, M. & Arck, P. C. Vertically transferred immunity in neonates: mothers, mechanisms and mediators. Front. Immunol. 11, 555 (2020).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  119. 119.

    Wiciński, M., Sawicka, E., Gębalski, J., Kubiak, K. & Malinowski, B. Human milk oligosaccharides: health benefits, potential applications in infant formulas, and pharmacology. Nutrients 12, 266 (2020).

    PubMed Central  Article  CAS  Google Scholar 

  120. 120.

    Berlutti, F. et al. Antiviral properties of lactoferrin — a natural immunity molecule. Molecules 16, 6992–7012 (2011).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  121. 121.

    Conesa, C. et al. Isolation of lactoferrin from milk of different species: calorimetric and antimicrobial studies. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 150, 131–139 (2008).

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  122. 122.

    Pannaraj, P. S. et al. Shared and distinct features of human milk and infant stool viromes. Front. Microbiol. 9, 1162 (2018).

    PubMed  PubMed Central  Article  Google Scholar 

  123. 123.

    Duranti, S. et al. Maternal inheritance of bifidobacterial communities and bifidophages in infants through vertical transmission. Microbiome 5, 66 (2017).

    PubMed  PubMed Central  Article  Google Scholar 

  124. 124.

    Goodrich, J. K. et al. Human genetics shape the gut microbiome. Cell 159, 789–799 (2014).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  125. 125.

    Goodrich, J. K. et al. Genetic determinants of the gut microbiome in UK twins. Cell Host Microbe 19, 731–743 (2016).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  126. 126.

    Xie, H. et al. Shotgun metagenomics of 250 adult twins reveals genetic and environmental impacts on the gut microbiome. Cell Syst. 3, 572–584.e3 (2016).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  127. 127.

    Rothschild, D. et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 555, 210–215 (2018).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  128. 128.

    Moreno-Gallego, J. L. et al. Virome diversity correlates with intestinal microbiome diversity in adult monozygotic twins. Cell Host Microbe 25, 261–272.e5 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  129. 129.

    Orth, G. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin. Immunol. 18, 362–374 (2006).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  130. 130.

    Clarke, E. L. et al. T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiency. Genome Med. 10, 70 (2018).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  131. 131.

    Zuo, T. et al. Human–gut–DNA virome variations across geography, ethnicity, and urbanization. Cell Host Microbe 28, 741–751.e4 (2020).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  132. 132.

    Holtz, L. R. et al. Geographic variation in the eukaryotic virome of human diarrhea. Virology 468, 556–564 (2014).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  133. 133.

    Gregory, A. C. et al. The Gut Virome Database reveals age-dependent patterns of virome diversity in the human gut. Cell Host Microbe 28, 724–740.e8 (2020).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  134. 134.

    Rampelli, S. et al. Characterization of the human DNA gut virome across populations with different subsistence strategies and geographical origin. Environ. Microbiol. 19, 4728–4735 (2017).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  135. 135.

    Neil, J. A. & Cadwell, K. The intestinal virome and immunity. J. Immunol. 201, 1615–1624 (2018).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  136. 136.

    Seo, S. U. & Kweon, M. N. Virome–host interactions in intestinal health and disease. Curr. Opin. Virol. 37, 63–71 (2019).

    PubMed  Article  PubMed Central  Google Scholar 

  137. 137.

    Moghadam, M. T. et al. How phages overcome the challenges of drug resistant bacteria in clinical infections. Infect. Drug Resist. 13, 45–61 (2020).

    Article  Google Scholar 

  138. 138.

    Kortright, K. E., Chan, B. K., Koff, J. L. & Turner, P. E. Phage therapy: a renewed approach to combat antibiotic-resistant bacteria. Cell Host Microbe 25, 219–232 (2019).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  139. 139.

    Galtier, M. et al. Bacteriophages targeting adherent invasive Escherichia coli strains as a promising new treatment for Crohn’s disease. J. Crohns Colitis 11, 840–847 (2017).

    PubMed  PubMed Central  Google Scholar 

  140. 140.

    Taylor, V. L., Fitzpatrick, A. D., Islam, Z. & Maxwell, K. L. The diverse impacts of phage morons on bacterial fitness and virulence. Adv. Virus Res. 103, 1–31 (2019).

    CAS  PubMed  Article  Google Scholar 

  141. 141.

    Modi, S. R., Lee, H. H., Spina, C. S. & Collins, J. J. Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome. Nature 499, 219–222 (2013).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  142. 142.

    Boling, L. et al. Dietary prophage inducers and antimicrobials: toward landscaping the human gut microbiome. Gut Microbes 11, 721–734 (2020).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  143. 143.

    Sweere, J. M. et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science 363, eaat9691 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  144. 144.

    Gogokhia, L. et al. Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis. Cell Host Microbe 25, 285–299.e8 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  145. 145.

    Lindfors, K. et al. Metagenomics of the faecal virome indicate a cumulative effect of enterovirus and gluten amount on the risk of coeliac disease autoimmunity in genetically at risk children: the TEDDY study. Gut 69, 1416–1422 (2019).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  146. 146.

    Khan Mirzaei, M. et al. Bacteriophages isolated from stunted children can regulate gut bacterial communities in an age-specific manner. Cell Host Microbe 27, 199–212.e5 (2020).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  147. 147.

    Desai, C. et al. Growth velocity in children with environmental enteric dysfunction is associated with specific bacterial and viral taxa of the gastrointestinal tract in Malawian children. PLoS Negl. Trop. Dis. 14, e0008387 (2020).

    PubMed  PubMed Central  Article  Google Scholar 

  148. 148.

    Lee, S. & Baldridge, M. T. Viruses RIG up intestinal immunity. Nat. Immunol. 20, 1563–1564 (2019).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  149. 149.

    Kernbauer, E., Ding, Y. & Cadwell, K. An enteric virus can replace the beneficial function of commensal bacteria. Nature 516, 94–98 (2014).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  150. 150.

    Ingle, H. et al. Viral complementation of immunodeficiency confers protection against enteric pathogens via interferon-λ. Nat. Microbiol. 4, 1120–1128 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  151. 151.

    Liu, L. et al. Commensal viruses maintain intestinal intraepithelial lymphocytes via noncanonical RIG-I signaling. Nat. Immunol. 20, 1681–1691 (2019).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  152. 152.

    Pérez-Brocal, V. et al. Metagenomic analysis of Crohn’s disease patients identifies changes in the virome and microbiome related to disease status and therapy, and detects potential interactions and biomarkers. Inflamm. Bowel Dis. 21, 2515–2532 (2015).

    PubMed  Article  PubMed Central  Google Scholar 

  153. 153.

    Ma, Y., You, X., Mai, G., Tokuyasu, T. & Liu, C. A human gut phage catalog correlates the gut phageome with type 2 diabetes. Microbiome 6, 24 (2018).

    PubMed  PubMed Central  Article  Google Scholar 

  154. 154.

    Ungaro, F. et al. Metagenomic analysis of intestinal mucosa revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory bowel disease. Gut Microbes 10, 149–158 (2019).

    CAS  PubMed  Article  Google Scholar 

  155. 155.

    Legoff, J. et al. The eukaryotic gut virome in hematopoietic stem cell transplantation: new clues in enteric graft-versus-host disease. Nat. Med. 23, 1080–1085 (2017).

    CAS  PubMed  Article  Google Scholar 

  156. 156.

    Łoś, M. & Wegrzyn, G. in Advances in Virus Research Vol. 82 339–349 (Academic Press, 2012).

  157. 157.

    Drew, H. R. et al. Structure of a B-DNA dodecamer: conformation and dynamics. Proc. Natl Acad. Sci. USA 78, 2179–2183 (1981).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  158. 158.

    Schulz, F. et al. Giant virus diversity and host interactions through global metagenomics. Nature 578, 432–436 (2020).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  159. 159.

    Wang, Y., Hammes, F., Düggelin, M. & Egli, T. Influence of size, shape, and flexibility on bacterial passage through micropore membrane filters. Environ. Sci. Technol. 42, 6749–6754 (2008).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  160. 160.

    Weil, A. A., Becker, R. L. & Harris, J. B. Vibrio cholerae at the intersection of immunity and the microbiome. mSphere 4, e00597-19 (2019).

    PubMed  PubMed Central  Article  Google Scholar 

  161. 161.

    Ryan, M. P. & Pembroke, J. T. Brevundimonas spp: emerging global opportunistic pathogens. Virulence 9, 480–493 (2018).

    PubMed  PubMed Central  Article  Google Scholar 

  162. 162.

    Roux, S. et al. Towards quantitative viromics for both double-stranded and single-stranded DNA viruses. PeerJ 2016, e2777 (2016).

    Article  CAS  Google Scholar 

  163. 163.

    Kim, K. H. & Bae, J. W. Amplification methods bias metagenomic libraries of uncultured single-stranded and double-stranded DNA viruses. Appl. Environ. Microbiol. 77, 7663–7668 (2011).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  164. 164.

    Krishnamurthy, S. R., Janowski, A. B., Zhao, G., Barouch, D. & Wang, D. Hyperexpansion of RNA bacteriophage diversity. PLOS Biol. 14, e1002409 (2016).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  165. 165.

    Callanan, J. et al. Expansion of known ssRNA phage genomes: from tens to over a thousand. Sci. Adv. 6, eaay5981 (2020).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  166. 166.

    Salter, S. J. et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 12, 87 (2014).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  167. 167.

    Kim, D. et al. Optimizing methods and dodging pitfalls in microbiome research. Microbiome 5, 1–14 (2017).

    Article  Google Scholar 

  168. 168.

    Zolfo, M. et al. Detecting contamination in viromes using ViromeQC. Nat. Biotechnol. 37, 1408–1412 (2019).

    CAS  PubMed  Article  Google Scholar 

  169. 169.

    Fu, L., Niu, B., Zhu, Z., Wu, S. & Li, W. CD-HIT: accelerated for clustering the next-generation sequencing data. Bioinformatics 28, 3150–3152 (2012).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  170. 170.

    Taylor, L. J., Abbas, A. & Bushman, F. D. grabseqs: simple downloading of reads and metadata from multiple next-generation sequencing data repositories. Bioinformatics 36, 3607–3609 (2020).

    CAS  PubMed  Article  Google Scholar 

  171. 171.

    Roux, S., Enault, F., Hurwitz, B. L. & Sullivan, M. B. VirSorter: mining viral signal from microbial genomic data. PeerJ 3, e985 (2015).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  172. 172.

    Ren, J., Ahlgren, N. A., Lu, Y. Y., Fuhrman, J. A. & Sun, F. VirFinder: a novel k-mer based tool for identifying viral sequences from assembled metagenomic data. Microbiome 5, 69 (2017).

    PubMed  PubMed Central  Article  Google Scholar 

  173. 173.

    Tithi, S. S., Aylward, F. O., Jensen, R. V. & Zhang, L. FastViromeExplorer: a pipeline for virus and phage identification and abundance profiling in metagenomics data. PeerJ 2018, e4227 (2018).

    Article  CAS  Google Scholar 

  174. 174.

    Roux, S., Tournayre, J., Mahul, A., Debroas, D. & Enault, F. Metavir 2: new tools for viral metagenome comparison and assembled virome analysis. BMC Bioinforma. 15, 76 (2014).

    Article  CAS  Google Scholar 

  175. 175.

    Jurtz, V. I., Villarroel, J., Lund, O., Voldby Larsen, M. & Nielsen, M. MetaPhinder — identifying bacteriophage sequences in metagenomic data sets. PLoS ONE 11, e0163111 (2016).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  176. 176.

    Rampelli, S. et al. ViromeScan: a new tool for metagenomic viral community profiling. BMC Genomics 17, 165 (2016).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  177. 177.

    Bolduc, B. et al. vConTACT: an iVirus tool to classify double-stranded DNA viruses that infect archaea and bacteria. PeerJ 2017, e3243 (2017).

    Article  Google Scholar 

  178. 178.

    Hatcher, E. L. et al. Virus variation resource-improved response to emergent viral outbreaks. Nucleic Acids Res. 45, D482–D490 (2017).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  179. 179.

    Bateman, A. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 47, D506–D515 (2019).

    Article  CAS  Google Scholar 

  180. 180.

    Grazziotin, A. L., Koonin, E. V. & Kristensen, D. M. Prokaryotic virus orthologous groups (pVOGs): a resource for comparative genomics and protein family annotation. Nucleic Acids Res. 45, D491–D498 (2017).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  181. 181.

    El-Gebali, S. et al. The Pfam protein families database in 2019. Nucleic Acids Res. 47, D427–D432 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  182. 182.

    Skewes-Cox, P., Sharpton, T. J., Pollard, K. S. & DeRisi, J. L. Profile hidden Markov models for the detection of viruses within metagenomic sequence data. PLoS ONE 9, e105067 (2014).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  183. 183.

    Clarke, E. L. et al. Sunbeam: an extensible pipeline for analyzing metagenomic sequencing experiments. Microbiome 7, 46 (2019).

    PubMed  PubMed Central  Article  Google Scholar 

  184. 184.

    Tisza, M. J. et al. Discovery of several thousand highly diverse circular DNA viruses. eLife 9, e51971 (2020).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  185. 185.

    Zhao, G. et al. VirusSeeker, a computational pipeline for virus discovery and virome composition analysis. Virology 503, 21–30 (2017).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  186. 186.

    McNair, K., Bailey, B. A. & Edwards, R. A. PHACTS, a computational approach to classifying the lifestyle of phages. Bioinformatics 28, 614–618 (2012).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  187. 187.

    Arndt, D. et al. PHASTER: a better, faster version of the PHAST phage search tool. Nucleic Acids Res. 44, W16–W21 (2016).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

Download references


The authors thank members of the Bushman laboratory for help and suggestions, and L. Zimmerman for artwork designs. This work was supported by the National Institutes of Health (NIH) (grants R61-HL137063, R01-HL113252), the Penn Center for AIDS Research (P30 AI 045008), the PennCHOP Microbiome Program and a Tobacco Formula grant under the Commonwealth Universal Research Enhancement (CURE) programme (grant number SAP # 4100068710), and the Crohn’s and Colitis Foundation.

Author information




The authors contributed equally to all aspects of the article.

Corresponding authors

Correspondence to Guanxiang Liang or Frederic D. Bushman.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Peer review information

Nature Reviews Microbiology thanks F. Maggi and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Temperate phages

Phages that are able to grow via both lytic and lysogenic replication pathways.

Viral contigs

Contiguous sequences assembled from overlapping sequence reads, which are then annotated as whole or partial viral genomes.

Multiple displacement amplification

A whole-genome amplification method, which starts by binding random primers to the template DNA and is then followed by strand displacement DNA synthesis performed by DNA polymerase, usually Φ29 DNA polymerase.

Primary immunodeficiencies

A group of rare immune disorders caused by genetic defects.


The first stool of a neonate.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Liang, G., Bushman, F.D. The human virome: assembly, composition and host interactions. Nat Rev Microbiol (2021).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing